ABBRATECH INC.

AbbraTech – Recombinant antibody discovery

ABBRATECH INC. is a biotech company in Guilford, United States, founded in 2022. It has raised $15.1M across 7 rounds, most recently a $551K Grant in August 2025.

Employees
1–10
Founded
2022
Total Funding
$15.1M
Last Round
$551K GrantAug 2025
Rounds
7

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 7 funding rounds and 2 investors for this company. to use credits for reveals, or explore the API.

About

AbbraTech develops a platform for discovering antibodies against disease targets that conventional approaches cannot access. Its EPIVOLVE technology drives antibody recognition of exposed regions of target proteins regardless of the underlying sequence. The company works alongside industry and academic partners to discover next-generation medicines.

Funding History

Data from Indexed.vcUpdated
GrantSBIR Phase II (NIH)Aug 2025
$551K

6 more events

  • Grant2024
  • Seed20232 investors
  • Grant2023

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Cloud/Infrastructure ×1
  • Other ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ABBRATECH INC. on Indexed.vc
<a href="https://indexed.vc/companies/abbratech-inc"><img src="https://indexed.vc/api/badge/company/abbratech-inc" alt="ABBRATECH INC. on Indexed.vc" width="260" height="76" /></a>